NCT00732771
- Conditions
- Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cardiovascular Diseases, +9 more
- Locations
-
- Novartis Investigator Site France
Clinical trial condition
Explore clinical trials studying Primary Hyperaldosteronism. Study availability and eligibility vary by location and protocol.
NCT00732771
NCT05636995